Table 1 Baseline Characteristic of participants
Total (n = 35) | Control (n = 19) | Intervention (n = 16) | Control vs. Intervention *(P) | |
|---|---|---|---|---|
Sex | 18 W, 17 M | 8 W, 11 M | 10 W, 6 M | 0.229 |
Age (years) | 43.5 (6.7) | 43.3 (4.3) | 43.8 (8.8) | 0.486 |
Body Mass Index (kg/m2) | 24.8 (3.7) | 25.9 (4) | 23.5 (3) | 0.069 |
First episode LBP (years) | 11.1 (7.4) | 9.9 (5.6) | 12.5 (9.1) | 0.517 |
VAS (0–10) | 5 (2.5) | 4.6 (2.7) | 5.4 (2.3) | 0.529 |
RMQ (0–24) | 7.5 (4.8) | 6.8 (4.9) | 8.3 (4.7) | 0.238 |
Activation TrA - PBU (mmHg) | 2.3 (2.25) | 2.7 (2.71) | 1.9 (1.5) | 0.641 |
Electric Activity TrA - EMGs | ||||
Resistance 10s (mV) | 0.053 (0.06) | 0.045 (0.03) | 0.064 (0.08) | 0.75 |
Thickness TrA - US | ||||
CSA resting (mm) | 3.76 (1.61) | 3.87 (1.77) | 3.63 (1.45) | 0.728 |
CSA contraction (mm) | 6.19 (1.99) | 6.51 (2.33) | 5.81 (1.49) | 0.436 |
CSA improvement (mm) | 2.42 (1.25) | 2.63 (1.24) | 2.18 (1.25) | 0.389 |